Guidelines recommend that carotid endarterectomy be performed within two weeks of stroke in patients with symptomatic carotid stenosis. Because a Swedish registry study showed patients treated within the first days after a transient ischemic attack or stroke are at increased risk of death and perioperatory stroke, this study aims at verifying this risk in<a href="https://solaci.org/en/2016/10/21/when-to-intervene-a-symptomatic-carotid-stenosis/" title="Read more" >...</a>
There are no data outside controlled studies, neither are there long term outcomes, on carotid artery stenting. This study was designed to assess the long term effectiveness of carotid stenting to prevent strokes in a large number of real life patients. This registry included prospective data with a strict follow up protocol on 901<a href="https://solaci.org/en/2016/09/26/carotid-pci-at-long-term-effective-in-stroke-prevention/" title="Read more" >...</a>
Original Title: Beta-blocker use is associated with lower stroke and death after carotid artery stenting. Reference: Tammman Obeid, et al. J Vasc. Surg. 2016;63:363-9. Courtesy of Dr. Carlos Fava. The latest trials on Carotid Artery Stenting (CAS) have shown significantly improved effectiveness. The use of drugs such as beta blockers (BB) have proved beneficial in some<a href="https://solaci.org/en/2016/03/01/beta-blockers-could-improve-outcomes-in-carotid-artery-stenting/" title="Read more" >...</a>
Original Title: Randomized Trial of stent versus Surgery for Asymptomatic Carotid Stenosis. Kenneth Rosenfield. N Engl J Med. 2016 Feb 17. [Epub ahead of print] Courtesy of Dr. Carlos Fava. Stokes are one of the main causes of death and disability in the world and up to 20% of strokes can be explained by carotid stenosis.<a href="https://solaci.org/en/2016/02/24/carotid-stenting-similar-to-surgery-in-asymptomatic-patients/" title="Read more" >...</a>
Original title: Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection. Reference: Hornung M et al. EuroIntervention. 2014; Epub ahead of print. This series of the Frankfurt CardioVascular Center included 124 consecutive patients undergoing carotid angioplasty with proximal protection. The first 92 patients received the Gore Flow Reversal System (WL Gore;<a href="https://solaci.org/en/2014/07/31/proximal-protection-devices-could-be-the-first-choice-for-most-carotid-artery-stenting-procedures/" title="Read more" >...</a>
Original title: A Direct Comparison of Early and Late Outcomes with Three Approaches to Carotid Revascularization and Open Heart Surgery. Reference: Mehdi H. Shishehbor et al. J Am Coll Cardiol, article in press. The prevalence of severe carotid stenosis (> 80%) in patients planning to have a Central Venous Catheter (CVC) is estimated at between 6 and<a href="https://solaci.org/en/2013/08/08/carotid-angioplasty-prior-to-central-venous-catheter-the-best-option-to-solve-combined-problems/" title="Read more" >...</a>
Original title: Prospective, Multicenter European Study of the GORE Flor Reversal System for Providing Neuroprotection During Carotid Artery Stenting Reference: Dimitrios Nikas, et, al.Catheterization and Cardiovascular Intervention 80:1060-1068 Cerebral protection systems (CPS) have proved useful in carotid angioplasty stenting (CAS), although it is not clear what the advantages are in respect to carotid endarterectomy, except in high risk<a href="https://solaci.org/en/2012/12/12/are-reversal-flow-cerebral-protection-devices-useful-in-carotid-angioplasty/" title="Read more" >...</a>
Original title: Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients Reference: Neil J. Wimmer et al. 2012;43: 3218-3224 Stroke. There are many patients with high surgical risk for carotid endarterectomy, either because of unfavorable anatomy, comorbidities or both. In this situation carotid angioplasty is a therapeutic option. However, no score has been<a href="https://solaci.org/en/2012/11/28/risk-score-for-carotid-angioplasty/" title="Read more" >...</a>
Chronic total occlusion (CTO) affect up to 20% of patients undergoing angiographic diagnostic tests. During the last two decades, recanalization technique refinement, the development of specific devices and operator skill improvement have elevated procedural success rate up to 90%. However, there are still particular complications such as collateral perforation and access site complications. This is<a href="https://solaci.org/en/2024/04/25/ercto-registry-chronic-total-occlusion-treatment-outcomes/" title="Read more" >...</a>
Discover the most read scientific articles on interventional cardiology of 2022 in our website. The FDA Approves Intravascular Lithotripsy for Calcified Lesions The US Food and Drug Administration (FDA) has cleared the shockwave lithotripsy system to treat severely calcified plaque lesions. Is Epinephrine Superior to Adenosine in No-REFLOW? In patients with acute coronary syndrome, no-reflow prevalence is 32%. Different drugs—such as adenosine, verapamil,<a href="https://solaci.org/en/2023/01/05/interventional-cardiology-the-most-read-articles-of-2022-in-solaci-org/" title="Read more" >...</a>